Mark Krause
Head
Plasma Proteins
Therapure Biopharma Inc
Canada
Biography
Mark joined Therapure in February of 2011. Prior to joining Therapure he held progressively senior positions within the finance operations at Valeant (formerly Biovail) culminating as Director, Financial Analysis and Planning. Mark worked closely with business development, R&D, and manufacturing particularly during licensing transactions where he was a member of the negotiating team with a focus on determining structure and value of transactions. Mark has a BSc in Biology from the University of British Columbia, an MBA from Richard Ivey School of Business and is a Certified Professional Accountant.
Research Interest
finance operations, Financial Analysis and Planning. Mark worked closely with business development, R&D, and manufacturing